한글목차

에쿠올(S-에쿠올/에쿠올)은 '단일 활성 성분'의 개념에서 산업화된 원료와 전달 기술의 생태계로 진화했습니다.

이 분야에서의 상업적 성공은 학문적 차별화가 아닌 순도 계층화 및 제형 설계를 통해 이루어지고 있습니다. 실제로 에쿠올에 대한 수요는 여성 건강과 기능성 웰빙에 뿌리를 두고 있으며, 주요 구매 기준은 일관된 분석 정확도(99% 이상 vs 99% 미만), 로트 간 재현성, 그리고 확장 가능한 변환 및 제형 능력(정제 vs 캡슐)입니다. 특정 관할권에서는 소송 결과에 따라 특정 에쿠올 관련 제품의 판매가 사실상 제한될 수 있기 때문에 사업 전개 자유도와 컴플라이언스 준수를 준수하는 상업화가 비즈니스 모델에 필수적인 요소로 작용하고 있습니다.

시장 확대는 점점 더 가치 중심이 되고 있으며, 가격 및 제품 구성의 고도화가 순수한 수량 성장을 능가하고 있습니다. 세계 판매량은 2021년 5,526kg에서 2026년 예상치인 6,758kg으로 증가했으며, 같은 기간 매출은 869만 달러에서 1,295만 달러로 확대됐습니다. 2025년 시장 규모는 6,357kg, 매출액은 1,088만 달러, 평균 가격은 약 1,711달러/kg으로 예측됩니다. 2026년부터 2032년까지의 예측 기간 동안 매출액 CAGR은 약 8.7%인 반면, 수량 CAGR은 약 5.1%로, 에쿠올의 수익화가 프리미엄화 및 제형 업그레이드에 의해 구조적으로 뒷받침되고 있음을 보여줍니다.

공급구조는 중앙집중화가 진행되어 가격대별 계층화가 두드러집니다. 2025년 상위 5개사(Daicel, Ningbo Inno Pharmchem, Shenghe Everything(Shanghai) Biotechnology, Wuhan Finetech Industry, Shanghai Banglin Biotechnology)가 공급량의 약 60.8%, 매출의 약 74.8%를 차지할 것으로 예측됩니다. 다이셀 단독으로는 생산량의 약 33.8%를 차지하는 반면, 매출액은 약 58.5%를 차지하며 두드러진 프리미엄 포지션을 반영하고 있습니다. 지역별로는 생산은 일본과 중국이 주도(2025년 기준 총 약 75% 점유율)하고, 수요는 아시아태평양이 중심(약 57% 점유율)입니다. 카테고리별로는 순도 99% 이상의 제품이 2025년 생산량의 약 69.9%, 매출의 약 74.1%를 차지할 것으로 예측됩니다. 용도별로는 정제가 기반(생산량 점유율 약 68.3%)을 유지하고 있지만, 캡슐제의 성장이 더 빠르고 kg당 가격도 높아지면서 에쿠올의 가치 구조가 재편되고 있습니다.

세계 에쿠올 시장은 기업별, 지역별(국가별), 유형별, 용도별로 세분화되어 있습니다. 세계 에쿠올 시장의 기업, 이해 관계자 및 기타 참가자들은 보고서를 강력한 리소스로 사용함으로써 우위를 점할 수 있을 것입니다. 부문 분석은 2021년부터 2032년까지 지역별(국가별), 유형별, 용도별, 지역별 매출, 수익 및 예측에 초점을 맞추었습니다.

시장 세분화

기업별

• Daicel
• Anthem Biosciences
• Ningbo Inno Pharmchem
• Shenghe Everything(Shanghai)Biotechnology
• Wuhan Finetech Industry
• Hubei Xinmingtai Chemical
• Shanghai Banglin Biotechnology

유형별 부문

• 99% 이상
• 99% 미만

용도별 부문

• 정제
• 캡슐

주요 지역 및 국가

• 북미
• 유럽
• 중국
• 일본
• 기타 지역

영문목차

Equols (S-equol / equol) has evolved from a "single active" concept into an industrialized ingredient-and-delivery ecosystem, where commercial success is driven by purity tiering and dosage-form engineering rather than academic differentiation. In practice, Equols demand is anchored in women's health and functional wellness, and the key buying criteria are consistent assay (>=99% vs <99%), batch-to-batch reproducibility, and scalable conversion/formulation capabilities (Tablet vs Capsule). In select jurisdictions, litigation outcomes can effectively restrict the sale of specific equol-related products, making freedom-to-operate and compliant commercialization an integral part of the business model.

Market expansion is increasingly value-led, with pricing and mix upgrades outpacing pure volume growth. Global sales rose from 5,526 kg in 2021 to 6,758 kg in 2026E, while revenue increased from USD 8.69m to USD 12.95m over the same period. In 2025, the market delivered 6,357 kg and USD 10.88m, implying an average price of ~USD 1,711/kg. Over 2026-2032F, revenue CAGR is ~8.7% versus volume CAGR of ~5.1%, indicating that Equols monetization is structurally supported by premiumization and formulation upgrades.

Supplier structure is concentrated and increasingly stratified by price band. In 2025, the Top 5 producers (Daicel, Ningbo Inno Pharmchem, Shenghe Everything (Shanghai) Biotechnology, Wuhan Finetech Industry, Shanghai Banglin Biotechnology) captured ~60.8% of volume and ~74.8% of revenue. Daicel alone accounted for ~33.8% of volume but ~58.5% of revenue, reflecting a pronounced premium position. Regionally, production is dominated by Japan and China (~75% combined share in 2025), while demand is centered in Asia-Pacific (~57% share). By category, >=99% products represent ~69.9% of 2025 volume and ~74.1% of revenue; by application, Tablets remain the base (~68.3% volume share) but Capsules are growing faster and carry a higher price per kg, reshaping the value pool for Equols.

The global Equols market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Equols market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2021-2032.

Market Segmentation

By Company

• Daicel
• Anthem Biosciences
• Ningbo Inno Pharmchem
• Shenghe Everything (Shanghai) Biotechnology
• Wuhan Finetech Industry
• Hubei Xinmingtai Chemical
• Shanghai Banglin Biotechnology

Segment by Type

• >=99%
• <99%

Segment by Application

• Tablet
• Capsule

Major Region and Country

• North America
• Europe
• China
• Japan
• Other Regions

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Equols in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Equols manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region anaylsis by company, by Type, by Application, sales, revenue, and price for each segment, and by customer

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equols revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

Table of Contents

1 Market Overview

• 1.1 Equols Product Scope
• 1.2 Equols by Type
  • 1.2.1 Global Equols Sales by Type (2021 & 2025 & 2032)
  • 1.2.2 >=99%
  • 1.2.3 <99%
• 1.3 Equols by Application
  • 1.3.1 Global Equols Sales Comparison by Application (2021 & 2025 & 2032)
  • 1.3.2 Tablet
  • 1.3.3 Capsule
• 1.4 Global Equols Market Estimates and Forecasts (2021-2032)
  • 1.4.1 Global Equols Market Size in Value Growth Rate (2021-2032)
  • 1.4.2 Global Equols Market Size in Volume Growth Rate (2021-2032)
  • 1.4.3 Global Equols Price Trends (2021-2032)
• 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

• 2.1 Global Equols Market Size by Region: 2021 VS 2025 VS 2032
• 2.2 Global Equols Retrospective Market Scenario by Region (2021-2026)
  • 2.2.1 Global Equols Sales Market Share by Region (2021-2026)
  • 2.2.2 Global Equols Revenue Market Share by Region (2021-2026)
• 2.3 Global Equols Market Estimates and Forecasts by Region (2027-2032)
  • 2.3.1 Global Equols Sales Estimates and Forecasts by Region (2027-2032)
  • 2.3.2 Global Equols Revenue Forecast by Region (2027-2032)
• 2.4 Major Region and Emerging Market Analysis
  • 2.4.1 North America Equols Market Size and Prospective (2021-2032)
  • 2.4.2 Europe Equols Market Size and Prospective (2021-2032)
  • 2.4.3 China Equols Market Size and Prospective (2021-2032)
  • 2.4.4 Japan Equols Market Size and Prospective (2021-2032)
  • 2.4.5 India Equols Market Size and Prospective (2021-2032)

3 Global Market Size by Type

• 3.1 Global Equols Historic Market Review by Type (2021-2026)
  • 3.1.1 Global Equols Sales by Type (2021-2026)
  • 3.1.2 Global Equols Revenue by Type (2021-2026)
  • 3.1.3 Global Equols Price by Type (2021-2026)
• 3.2 Global Equols Market Estimates and Forecasts by Type (2027-2032)
  • 3.2.1 Global Equols Sales Forecast by Type (2027-2032)
  • 3.2.2 Global Equols Revenue Forecast by Type (2027-2032)
  • 3.2.3 Global Equols Price Forecast by Type (2027-2032)

4 Global Market Size by Application

• 4.1 Global Equols Historic Market Review by Application (2021-2026)
  • 4.1.1 Global Equols Sales by Application (2021-2026)
  • 4.1.2 Global Equols Revenue by Application (2021-2026)
  • 4.1.3 Global Equols Price by Application (2021-2026)
• 4.2 Global Equols Market Estimates and Forecasts by Application (2027-2032)
  • 4.2.1 Global Equols Sales Forecast by Application (2027-2032)
  • 4.2.2 Global Equols Revenue Forecast by Application (2027-2032)
  • 4.2.3 Global Equols Price Forecast by Application (2027-2032)
• 4.3 New Sources of Growth in Equols Application

5 Competition Landscape by Players

• 5.1 Global Equols Sales by Players (2021-2026)
• 5.2 Global Top Equols Players by Revenue (2021-2026)
• 5.3 Global Equols Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equols as of 2025)
• 5.4 Global Equols Average Price by Company (2021-2026)
• 5.5 Global Key Manufacturers of Equols, Manufacturing Sites & Headquarters
• 5.6 Global Key Manufacturers of Equols, Product Type & Application
• 5.7 Global Key Manufacturers of Equols Founded Date

6 Region Analysis

• 6.1 China Market: Players, Segments, Downstream and Major Customers
  • 6.1.1 China Equols Sales by Company
  • 6.1.2 China Equols Sales Breakdown by Type (2021-2026)
  • 6.1.3 China Equols Sales Breakdown by Application (2021-2026)
  • 6.1.4 China Equols Major Customer
  • 6.1.5 China Market Trend and Opportunities
• 6.2 Japan Market: Players, Segments, Downstream and Major Customers
  • 6.2.1 Japan Equols Sales by Company
  • 6.2.2 Japan Equols Sales Breakdown by Type (2021-2026)
  • 6.2.3 Japan Equols Sales Breakdown by Application (2021-2026)
  • 6.2.4 Japan Equols Major Customer
  • 6.2.5 Japan Market Trend and Opportunities
• 6.3 India Market: Players, Segments, Downstream and Major Customers
  • 6.3.1 India Equols Sales by Company
  • 6.3.2 India Equols Sales Breakdown by Type (2021-2026)
  • 6.3.3 India Equols Sales Breakdown by Application (2021-2026)
  • 6.3.4 India Equols Major Customer
  • 6.3.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

• 7.1 Daicel Corporation
  • 7.1.1 Daicel Corporation Company Information
  • 7.1.2 Daicel Corporation Business Overview
  • 7.1.3 Daicel Corporation Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.1.4 Daicel Corporation Equols Products Offered
  • 7.1.5 Daicel Corporation Recent Development
• 7.2 Anthem Biosciences Private Limited.
  • 7.2.1 Anthem Biosciences Private Limited. Company Information
  • 7.2.2 Anthem Biosciences Private Limited. Business Overview
  • 7.2.3 Anthem Biosciences Private Limited. Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.2.4 Anthem Biosciences Private Limited. Equols Products Offered
• 7.3 Ningbo Inno Pharmchem
  • 7.3.1 Ningbo Inno Pharmchem Company Information
  • 7.3.2 Ningbo Inno Pharmchem Business Overview
  • 7.3.3 Ningbo Inno Pharmchem Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.3.4 Ningbo Inno Pharmchem Equols Products Offered
• 7.4 Shenghe Everything (Shanghai) Biotechnology
  • 7.4.1 Shenghe Everything (Shanghai) Biotechnology Company Information
  • 7.4.2 Shenghe Everything (Shanghai) Biotechnology Business Overview
  • 7.4.3 Shenghe Everything (Shanghai) Biotechnology Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.4.4 Shenghe Everything (Shanghai) Biotechnology Equols Products Offered
• 7.5 Wuhan Finetech Industry
  • 7.5.1 Wuhan Finetech Industry Company Information
  • 7.5.2 Wuhan Finetech Industry Business Overview
  • 7.5.3 Wuhan Finetech Industry Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.5.4 Wuhan Finetech Industry Equols Products Offered
• 7.6 Hubei Xinmingtai Chemical
  • 7.6.1 Hubei Xinmingtai Chemical Company Information
  • 7.6.2 Hubei Xinmingtai Chemical Business Overview
  • 7.6.3 Hubei Xinmingtai Chemical Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.6.4 Hubei Xinmingtai Chemical Equols Products Offered
• 7.7 Shanghai Banglin Biotechnology
  • 7.7.1 Shanghai Banglin Biotechnology Company Information
  • 7.7.2 Shanghai Banglin Biotechnology Business Overview
  • 7.7.3 Shanghai Banglin Biotechnology Equols Sales, Revenue and Gross Margin (2021-2026)
  • 7.7.4 Shanghai Banglin Biotechnology Equols Products Offered

8 Equols Manufacturing Cost Analysis

• 8.1 Equols Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Equols
• 8.4 Equols Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Equols Distributors List
• 9.3 Equols Customers
  • 9.3.1 OTSUKA Phamaceutical Co.Ltd.

10 Equols Market Dynamics

• 10.1 Equols Industry Trends
• 10.2 Equols Market Drivers
• 10.3 Equols Market Challenges
• 10.4 Equols Market Restraints

11 Research Findings and Conclusion

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
  • 12.1.2 Data Source
• 12.2 Author Details
• 12.3 Disclaimer